Home/ReNeuron/Keith Parrish

KP

Keith Parrish

Finance Director

Therapeutic Areas

Neurology Oncology Ophthalmology Genetic Diseases

ReNeuron Pipeline

Drug	Indication	Phase
CustomEX™ Platform	Targeted Drug Delivery	Preclinical
Exosome-based RNA Delivery	Undisclosed	Preclinical
Exosome-based Protein/Small Molecule Delivery	Undisclosed	Preclinical

Leadership Team at ReNeuron

Dr. Randolph Corteling

Managing Director & Chief Scientific Officer

Dr. Barbara Staehelin

Non-Executive Director

Dr. Samantha Thomas

Head of Research

View full ReNeuron profile